Biospecimens
Provide patient data and blood and tissue samples needed for research. With access to a broad cross-section of cancer patients and healthy patients participating in clinical trials, researchers will have greater opportunity to study both cancerous and normal cells provided through tissue and blood samples. These biospecimens are important because they allow researchers to study how cancer gets started, grows, and spreads (metastasizes) in some people and what prevents or halts this process in others. The pilot will assess how NCI’s guidelines for collecting and storing biospecimens can be applied nationwide to benefit the entire cancer research community.
